These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37294424)

  • 1. Decreased SIRT1 mRNA expression in peripheral blood mononuclear cells from patients with neuromyelitis optica spectrum disorders.
    Zhang L; Xue Y; Yuan C; Du X; Wang X; Guo L; Li B
    Acta Neurol Belg; 2023 Dec; 123(6):2287-2294. PubMed ID: 37294424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon Regulatory Factor 5 Gene Polymorphisms and mRNA Expression Levels Are Associated with Neuromyelitis Optica Spectrum Disorder.
    Wang G; Jing L; Wang Y; Mehmood A; Zhang H; Guo R; Zhang L; Li B
    Mol Neurobiol; 2024 Oct; 61(10):7989-7999. PubMed ID: 38451436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased mRNA Expressions of CD40L in Patients with Neuromyelitis Optica Spectrum Disorder.
    Shi Z; Feng L; Lian Z; Liu J; Chen H; Du Q; Zhang Y; Zhang Q; Yang M; Zhou H
    J Mol Neurosci; 2020 Apr; 70(4):610-617. PubMed ID: 31925706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of HLA-DP in patients with neuromyelitis optica spectrum disorders].
    Chang YY; Wang YG; Fan P; Wang JQ; Shu YQ; Li R; Zhong XN; Long L; Zhao ZH; Li CX; Qiu W
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(45):3574-3580. PubMed ID: 31826574
    [No Abstract]   [Full Text] [Related]  

  • 5. Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders.
    Brill L; Lavon I; Vaknin-Dembinsky A
    Mult Scler Relat Disord; 2019 May; 30():114-118. PubMed ID: 30771576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered non-coding RNA profiles and potential disease marker identification in peripheral blood mononuclear cells of patients with NMOSD.
    Zhou Y; Song S; Han Y; Liu J; Yin B; Yuan C; Guo R; Jia Z; Sun Y; Li B
    Int Immunopharmacol; 2022 Aug; 109():108899. PubMed ID: 35689955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder.
    Yin BW; Li B; Mehmood A; Yuan C; Song S; Guo RY; Zhang L; Ma T; Guo L
    CNS Neurosci Ther; 2021 Dec; 27(12):1549-1560. PubMed ID: 34637583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders.
    Li T; Li JW; Qin YH; Liu R; Xu XN; Li X; Li LM; Feng B; Yang L; Yang CS
    Ann Clin Transl Neurol; 2024 Jul; 11(7):1732-1749. PubMed ID: 38738556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.
    Min W; Zhang L; Wang S; Xue M; Guo C; Zhu M
    Mult Scler Relat Disord; 2023 Feb; 70():104517. PubMed ID: 36708681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder.
    Liang J; Liu J; Fan R; Chen Z; Chen X; Tong J; Chen Y; Peng F; Jiang Y
    Neuroimmunomodulation; 2019; 26(5):258-264. PubMed ID: 31655825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D
    Cho EB; Shin JH; Kwon S; Kim J; Seok JM; Kim BJ; Min JH
    Front Immunol; 2021; 12():677041. PubMed ID: 34394078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between
    Liu J; Wang G; Yang J; Wang Y; Guo R; Li B
    Transl Neurosci; 2024 Jan; 15(1):20220337. PubMed ID: 38584670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder.
    Yan H; Wang Y; Li Y; Shen X; Ma L; Wang M; Du J; Chen W; Xi X; Li B
    Neurol Sci; 2024 Feb; 45(2):709-718. PubMed ID: 37676374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.
    Yamashita K; Kinoshita M; Miyamoto K; Namba A; Shimizu M; Koda T; Sugimoto T; Mori Y; Yoshioka Y; Nakatsuji Y; Kumanogoh A; Kusunoki S; Mochizuki H; Okuno T
    J Neuroinflammation; 2018 Apr; 15(1):125. PubMed ID: 29703264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte Subsets Are Associated with Disease Status in Neuromyelitis Optica Spectrum Disorders.
    Yang H; Liu W; Wu YF; Zhu DS; Shen XF; Guan YT
    Neuroimmunomodulation; 2022; 29(4):296-305. PubMed ID: 34903694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered immune co-inhibitory receptor expression and correlation of LAG-3 expression to disease severity in NMOSD.
    Haham N; Zveik O; Rechtman A; Brill L; Vaknin-Dembinsky A
    J Neuroimmunol; 2024 Mar; 388():578289. PubMed ID: 38301597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
    Ostendorf L; Mothes R; van Koppen S; Lindquist RL; Bellmann-Strobl J; Asseyer S; Ruprecht K; Alexander T; Niesner RA; Hauser AE; Paul F; Radbruch H
    Front Immunol; 2019; 10():2725. PubMed ID: 31849944
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    Ma J; Yu H; Wang H; Zhang X; Feng K
    J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study.
    Xie H; Zhao Y; Pan C; Zhang J; Zhou Y; Li Y; Duan R; Yao Y; Gong Z; Teng J; Jia Y
    BMC Neurol; 2021 Oct; 21(1):389. PubMed ID: 34625035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Yuan C; Liu X; Cai S; Zhang L; Guo R; Jia Z; Sun Y; Li B
    Mult Scler Relat Disord; 2023 Feb; 70():104504. PubMed ID: 36623394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.